Omega-conotoxin MVIIC attenuates neuronal apoptosis in vitro and improves significant recovery after spinal cord injury in vivo in rats

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 3524-3536

  Oliveira, Karen M ^a   Lavor, Mário Sérgio L ^b   Silva, Carla Maria O ^a   Fukushima, Fabíola B ^c   Rosado, Isabel R ^a   Silva, Juneo F ^a   Martins, Bernardo C ^a   Guimarães, Laís B ^a   Gomez, Marcus Vinícius ^a   Melo, Marília M ^c   Melo, Eliane G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Bladder; Cell death; Clinical recovery; Conotoxin; In vitro; Neuron preservation

Indexed keywords

NEUROPROTECTIVE AGENT; OMEGA CONOTOXIN; OMEGA-CONOTOXIN-MVIIC;

ANIMAL; APOPTOSIS; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; IN VITRO STUDY; MALE; NERVE CELL; PATHOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; TUNEL ASSAY; WISTAR RAT;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; IN SITU NICK-END LABELING; IN VITRO TECHNIQUES; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OMEGA-CONOTOXINS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84906269600     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Tator CH. Strategies for recovery and regeneration after spinal cord injury. Inj Prev 2002; 8: iv33-iv36.
2. Rossignol S, Schwab M, Schwartz M, Fehlings MG. Spinal cord injury: time to move? J Neurosci 2008; 27: 11782-11792.
3. Lee BB, Cripps RA, Fitzharris M, Wing PC. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord 2014; 52: 110-6.
4. Isaac L and Pejic L. Secondary mechanisms of spinal cord injury. Surg Neurol 1995; 43: 484-485.
5. Amar AP and Levy M. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord. Neurosurg 1999; 44: 1027-1039.
6. Decuypere JP, Monaco G, Missiaen L, De Smedt H, Parys JB, Bultynck G. IP3 receptors, mitochondria, and Ca2+ signaling: implications for aging. J Aging Res 2011; 2011: 1-20.
7. Liu WM, Wu JY, Li FC, Chen QX. Ion channel blockers and spinal cord injury. J Neurosci Res 2011; 89: 791-801.
8. Dasuri K, Zhang L, Keller JN. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radical Bio Med 2013; 62: 170-185.
9. Hulsebosch CE. Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 2002; 26: 238-255.
10. Ackery A, Tator C, Krassioukov A. A global perspective on spinal cord injury epidemiology. J Neurotraum 2004; 21: 1355-1370.
11. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004; 4: 451-464.
12. Talac R, Friedman JA, Moore MJ, Jabbari E, Windebank AJ, Currier BL, Yaszemski MJ. Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies. Biomaterials 2004; 25: 1505-1510.
13. Guertin PA. Paraplegic mice are leading to new advances in spinal cord injury research. Spinal Cord 2005; 43: 459-461.
14. Benevento BT and Sipski ML. Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury. Phys Ther 2002; 82: 601-612.
15. Leung PY, Johnson CS, Wrathall JR. Comparison of the effects of complete and incomplete spinal cord injury on lower urinary tract function as evaluated in unanesthetized rats. Exp Neurol 2007; 208: 80-91.
16. Torres BBJ, Serakides R, Caldeira F, Gomes M, Melo E. The ameliorating effect of dantrolene on the morphology of urinary bladder in spinal cord injured rats. Pathol Res Pract 2011; 207: 775-779.
17. Jia X, Kowalski RG, Sciubba DM, Geocadin RG. Critical Care of Traumatic Spinal Cord Injury. J Intensiv Care Med 2013; 28: 12-23.
18. Choi DW. Excitotoxicity cell death. J Neurobiol 1992; 23: 1261-1276.
19. Lanz O, Bergman R, Shell L. Initial assessment of patients with spinal cord trauma. Vet Med 2000; 95: 851-854.
20. Aslan A, Cemek M, Buyukokuroglu ME, Altunbas K, Bas O, Yurunez Y, Cosar M. Dantrolene can reduce secondary damage after spinal cord injury. Eur Spine J 2009; 18: 1442-1451.
21. Torres BB, Caldeira FM, Gomes MG, Serakides R, de Marco Viott A, Bertagnolli AC, Fukushima FB, de Oliveira KM, Gomes MV, de Melo EG. Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats. Int J Exp Path 2010; 91: 530-536.
22. Liu ZQ, Xing SS, Zhang W. Neuroprotective effect of curcumin on spinal cord in rabbit model with ischemia/reperfusion. J Spinal Cord Med 2013; 36: 147-152.
23. Valentino K, Newcomb R, Gardbois T, Singh T, Bowersox S, Bitner S, Justice A, Yamashiro D, Hoffman BB, Ciaranello R, Miljanich G, Ramachandran J. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci U S A 1993; 90: 7894-7897.
24. Buchan AM, Gertler SZ, Li H, Xue D, Huang ZG, Chaundy KE, Barnes K, Lesiuk HJ. A Selective N-Type Ca2+-Channel Blocker Prevents Cal Injury 24 h Following Severe Forebrain Ischemia and Reduces Infarction Following Focal Ischemia. J Cereb Blood Flow Metab 1994; 14: 903-910.
25. Hovda DA, Fu K, Badie H, Samii A, Pinanong P, Becker DP. Administration of an omegaconopeptide one hour following traumatic brain injury reduces 45calcium accumulation. Acta Neurochir Suppl 1994; 60: 521-523.
26. Bowersox SS, Singh T, Luther RR. Selective blockade of N-type voltage-sensitive calcium channel protects against brain injury after transient focal cerebral ischemia in rats. Brain Res 1997; 747: 343-347.
27. Verweij BH, Muizelaar JP, Vinas FC, Peterson PL, Xiong Y, Lee CP. Improvement in mitochondrial dysfunction as a new surrogate efficiency measure for preclinical trials: dose-response and time-window profiles for administration of the calcium channel blocker Ziconotide in experimental brain injury. J Neurosurg 2000; 93: 829-834.
28. Hillyard DR, Monje VD, Mintz IM, Bean BP, Nadasdi L, Ramachandran J, Miljanich G, Azimi-Zoonooz A, McIntosh JM, Cruz LJ, Imperial JS, Olivera BM. A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron 1992; 9: 69-77.
29. Olivera BM, Miljanich G, Ramachandran J, Adams ME. Calcium channel diversity and neu rotransmitter release: the ?-conotoxins and ?-agatoxins. Ann Rev Biochem 1994; 63: 823-867.
30. Uchitel OD. Toxins affecting calcium channels in neurons. Toxicon 1997; 35: 1161-1191.
31. 2+ channels. FEBS Let 2001; 491: 127-130.
32. Kapoor VK. Natural toxins and their therapeutic potential. Indian J Exp Biol 2010; 48: 228-237.
33. Turner TJ, Lampe RA, Dunlap K. Characterization of presynaptic calcium channels with ?-conotoxin MVIIC and ?-grammotoxin SIA: role for a resistant calcium channel type in neurosecretion. Mol Interv 1995; 47: 348-353.
34. Gonçaves JM, Ferreira J, Prado MA, Cordeiro MN, Richardson M, Pinheiro CAN, Silva MAR, Castro Junior CJ, Souza AH, Gomez MV. The effect of spider toxin PhTx3-4, ?-conotoxins MVIIA and MVIIC on glutamate uptake and on capsaicin-induced glutamate release and [Ca2+]i in spinal cord synaptosomes. Cell Mol Neurobiol 2011; 31: 277-283.
35. 2+ channel. J Biol Chem 1996; 271: 13804-13810.
36. McDonough SI, Boland LM, Mintz IM, Bean BP. Interactions among toxins that inhibit N-type and P-type calcium channels. J Gen Physiol 2002; 119: 313-328.
37. Pinheiro AC, Silva AJ, Prado MA, Cordeiro Mdo N, Richardson M, Batista MC, de Castro Junior CJ, Massensini AR, Guatimosim C, Romano-Silva MA, Kushmerick C, Gomez MV. Phoneutria spider toxins block ischemia-induced glutamate release, neuronal death, and loss of neurotransmission in hippocampus. Hippocampus 2009; 19: 1123-1129.
38. Wright CE and Angus JA. Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission. Br J Pharmacol 1999; 119: 49-56.
39. Imaizumi T, Kocsis JD, Waxman SG. The role of voltage-gated Ca++ channels in anoxic injury of spinal cord matter. Brain Res 1999; 817: 84-92.
40. Gensel JC, Tovar CA, Bresnaham JC, Beattle MS. Topiramate treatment is neuroprotective and reduces oligodendrocytes loss after cervical spinal cord injury. PLoS One 2012; 7: 1-6.
41. Moghaddasi M, Velumian AA, Zhang L, Fehlings MG. An ex vivo preparation of mature mice spinal cord to study synaptic transmission on motoneurons. J Neurosc Met 2007; 159: 1-7.
42. Solaroglu I, Kaptanoglu E, Okutan O, Beskonakli E, Attar A, Kilinc K. Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. Surg Neurol 2005; 64: 17-21.
43. Kamada T, Koda M, Dezawa M, Anahara R, Toyama Y, Yoshinaga K, Hashimoto M, Koshizuta S, Nishio Y, Mannoji C, Okawa A, Yamazaki M. Transplantation of human bone marrow stromal cell-derived Schwann cells reduces cystic cavity and promotes functional recovery after contusion injury of adult rat spinal cord. Neuropathol 2011; 31: 48-58.
44. Basso M, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion the NYU weight-drop device versus transection. Exp Neurol 1996; 139: 244-256.
45. Agrawal SK, Nashimi R, Fehlings MG. Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord whtie matter injury. J Neurosci 2000; 99: 179-188.
46. Hazell AS. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem 2007; 50: 941-953.
47. Kunihara T, Matsuzaki K, Shiiya, N, Saijo Y, Yasuda K. Naloxone lowers cerebrospinal fluid levels of excitatory amino acids after thoracoabdominal aortic surgery. J Vasc Surg 2004; 40: 681-690.
48. Brouns R and Deyn PP. The complexity of neurobiological processes in acute ischemic stroke. Clinic Neurol Neurosurg 2009; 11: 483-495.
49. Rowland JW, Hawryluk GMD, Kwon B, Fehlings M. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008; 25: 1-17.
50. Greenberg DA. Calcium channels in neurological disease. Ann Neurol 1997; 42: 275-282.
51. Berridge MJ. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 2002; 32: 235-249.
52. Ruiz A, Matute C, Alberdi E. Endoplasmic reticulum Ca2+ release through ryanodine and IP3 receptors contributes to neuronal excitotoxicity. Cell Calcium 2009; 46: 273-281.
53. Regan RF, Choi DW. The effect of NMDA, AMPA/kainate, and calcium channel antagonists on traumatic cortical neuronal injury in culture. Brain Res 1994; 633: 236-242.
54. Springer JE, Azbill RD, Nottingham SA, Kennedy SE. Calcineurin mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J Neurosci 2000; 20: 7246-7251.
55. Kochegarov AA. Pharmacological modulators of voltage-gated calcium channels and their therapeutical application. Cell Calcium 2003; 33: 145-162.
56. Sullivan PG, Springer JE, Hall ED, Scheff SW. Mitochondrial uncoupling as a therapeutic target following neuronal injury. J Bioenerg Biomembr 2004; 36: 353-356.
57. Pinheiro AC, Gomez RS, Massensini AR, Cordeiro MN, Richardson M, Romano-Silva MA, Prado MA, De Marco L, Gomez MV. Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer. Neurochem Internat 2006; 49: 543-547.
58. Zhang L, Andou Y, Masuda S, Mitani A, Kataoka K. Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett 1993; 58: 105-108.
59. Nakayama R, Yano T, Ushijima K, Abe K, Terasaki H. Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemia. Anesthesiol 2002; 96: 705-710.
60. Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW, Dong HX, Wu YJ, Fan GS, Jacquin MF, Hsu CY, Choi DW. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 1997; 17: 5395-5406.
61. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000; 1: 120-129.
62. Dalmolin GD, Silva CR, Rigo FK, Gomes GM, Cordeiro MM, Richardson M, Silva MAR, Prado MAM, Gomez MV, Ferreira J. Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain. Pain 2011; 152: 2224-2332.
63. Kobayashi T and Mori Y. Ca2+ channel antagonists and neuroprotection from cerebral ischemia. Eur J Pharmacol 1998; 363: 1-15.
64. Triggle DJ. Drug targets in the voltage-gated calcium channel family: why some are and some are not. ASSAY Drug Dev Technol 2003; 1: 719-733.
65. Terlau H and Olivera BM. Conus venoms: a rich source of novel íon channel-targeted peptides. Physiol Rev 2004; 84: 41-68.
66. Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992; 116: 201-211.
67. Xu GP, Dave KR, Vivero R, Schmidt-Kastner R, Sick TJ, Pérez-Pinzón MA. Improvement in neuronal survival after ischemic preconditioning in hippocampal slice cultures. Brain Res 2002; 952: 153-8.
68. Kjell J, Codeluppi S, Josephson A, Abrams MB. Spatial and cellular characterization of mTORC1 activation after spinal cord injury reveals biphasic increase mainly attributed to microglia/macrophages. Brain Pathol 2014; [Epub ahead of print].
69. Yacoub A, Hajec MC, Stanger R, Wan W, Young H, Mathem BE. Neuroprotective effects of perflurocarbon (Oxycyte) after contusive spinal cord injury. J Neurol 2014; 31: 256-267.
70. Meyer J, Vialle LR, Vialle EN, Bleggi-Torres LF, Rasera E, Leonel I. Alterações vesicais na lesão medular experimental em ratos. Acta Cir Bras 2003; 18: 203-208.
71. Leung PY, Johnson CS, Wrathall JR. Comparison of the effects of complete and incomplete spinal cord injury on lower urinary tract function as evaluated in unanesthetized rats. Exp Neurol 2007; 208: 80-91.
72. Apodaca G, Kiss S, Ruiz W, Meyers S, Zeidel M, Birder L. Disruption of bladder epithelium barrier function after spinal cord injury. Am J Physiol Renal Physiol 2003; 284: F966-F976.
73. Herrera JJ, Haywood-Watson RJ 2nd, Grill RJ. Acute and chronic deficits in the urinary bladder after spinal contusion injury in the adult rat. J Neurotraum 2010; 27: 423-431.
74. Sato K, Raymond C, Martin-Moutot N, Sasaki T, Omori A, Ohtake A, Kim JI, Kohno T, Takahashi M, Seagar M. Binding of chimeric analogs of ?-conotoxin MVIIA and MVIIC to the N- and P/Q-type calcium channels. FEBS Let 1997; 414: 480-484.
75. McDonough SI, Swartz KJ, Mintz IM, Boland LM, Bean BP. Inhibition of calcium channels in rat central and peripheral neurons by ?-conotoxin MVIIC. J Neurosci 1996; 16: 2612-2623.
76. Bowersox SS and Luther R. Pharmacother- apeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in venom of Conus magus. Toxicon 1998; 36: 1651-1658.
77. Oliveira KM, Silva CM, Lavor MS, Rosado IR, Fukushima FB, Assumpção AL, Neves SM, Motta GR, Garcia FF, Gomez MV, Melo MM, Melo EG. Systemic effects induced by intralesional injection of ?-conotoxina MVIIC after spinal cord injury in rats. J Venom Anim Toxins Incl Trop Dis 2014; 20: 15.